GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cardiovascular Systems Inc (FRA:R7Y1) » Definitions » Total Equity

Cardiovascular Systems (FRA:R7Y1) Total Equity : €226.0 Mil (As of Dec. 2022)


View and export this data going back to 2012. Start your Free Trial

What is Cardiovascular Systems Total Equity?

Cardiovascular Systems's total equity for the quarter that ended in Dec. 2022 was €226.0 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Cardiovascular Systems Total Equity Historical Data

The historical data trend for Cardiovascular Systems's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardiovascular Systems Total Equity Chart

Cardiovascular Systems Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 115.11 130.93 238.69 224.90 236.01

Cardiovascular Systems Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 229.68 230.18 236.01 244.58 225.98

Cardiovascular Systems Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Cardiovascular Systems's Total Equity for the fiscal year that ended in Jun. 2022 is calculated as

Total Equity=Total Assets(Q: Jun. 2022 )-Total Liabilities(Q: Jun. 2022 )
=305.252-69.244
=236.0

Cardiovascular Systems's Total Equity for the quarter that ended in Dec. 2022 is calculated as

Total Equity=Total Assets(Q: Dec. 2022 )-Total Liabilities(Q: Dec. 2022 )
=294.062-68.078
=226.0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cardiovascular Systems Total Equity Related Terms

Thank you for viewing the detailed overview of Cardiovascular Systems's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Cardiovascular Systems (FRA:R7Y1) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cardiovascular Systems Inc (FRA:R7Y1) » Definitions » Total Equity
Comparable Companies
OM SIBN VREX OFIX NVRO UFPT RXST AORT KIDS IRMD ABT MDT SYK BSX SZSE:300760 EW DXCM ZBH ALGN PODD
Traded in Other Exchanges
N/A
Address
1225 Old Highway 8 Northwest, Saint Paul, MN, USA, 55112-6416
Website
https://www.csi360.com
Cardiovascular Systems Inc is a medical technology company focused on patients with peripheral and coronary artery diseases. Its peripheral artery disease systems are catheter-based platforms used to treat plaque in leg arteries above and below the knee. The firm's orbital atherectomy systems are used in peripheral and coronary commercial applications. Its OAS products include the Diamondback 360 Peripheral and Stealth 360 systems. Sales of Peripheral OAS contribute the majority of revenue. Cardiovascular systems generate the vast majority of its revenue in the United States.

Cardiovascular Systems (FRA:R7Y1) Headlines

No Headlines